Latest news with #HIMS
Time of India
3 days ago
- Health
- Time of India
Delhi Health Minister reviews key reforms, calls for critical care blocks in hospitals
New Delhi: Delhi Health Minister Pankaj Singh on Wednesday directed officials to identify suitable spaces within government hospitals for the immediate establishment of critical care blocks , along with addressing other key issues related to the healthcare system. The minister chaired a review meeting with senior officials of the Health Department and announced key reforms aimed at strengthening the public healthcare infrastructure across the national capital, according to an official statement. He said that under the central government's PM-Ayushman Bharat Health Infrastructure Mission (PM-ABHIM), officials have been directed to identify suitable spaces within government hospitals for the immediate establishment of critical care blocks. These blocks are intended to enhance emergency preparedness and improve access to advanced life-saving care, Singh said, adding, "To ensure patients are not forced to move between hospitals, the installation of dialysis machines must be expedited. We are working to increase the number of machines to over 300." In view of the upcoming monsoon season, the minister also stressed the importance of maintaining an uninterrupted supply of essential medicines. "No government hospital in Delhi should face a medicine shortage. Emergency procurement must be prioritised and completed within the stipulated timeframe," he added. The Health Minister further directed all government hospitals to complete registration under the Hospital Information Management System (HIMS) without delay, in accordance with prescribed protocols. He also said there are also plans to set up model health labs in Delhi, which will provide a wide range of essential diagnostic tests for the public. Highlighting the need for mental healthcare, Singh announced that brain health clinics, on the lines of the existing one at Indira Gandhi Hospital in Dwarka, will be established in all districts. "The Brain Health Clinic at Dwarka has received a good public response. We aim to replicate this model to ensure timely treatment for mental health issues across the city," he said.
Indian Express
3 days ago
- Health
- Indian Express
Delhi Health Minister Singh asks govt hospitals to set up critical care blocks under PM-ABHIM scheme
Delhi's Health Minister Dr Pankaj Kumar Singh on Wednesday directed the government hospitals to immediately set up critical care blocks under the Pradhan Mantri Ayushman Bharat Health Infrastructure Mission (PM-ABHIM) scheme. The Central government-funded scheme is aimed at strengthening the infrastructure of healthcare institutions at all levels. He asked department officials to conduct on-site inspections and identify available spaces within hospitals to set up these dedicated blocks. Minister Singh instructed the officials to expedite the installation of dialysis machines in government hospitals so that patients don't have to shuttle between hospitals for treatment. He said that the number of dialysis machines should be increased to over 300 across all hospitals. To prepare for the monsoon season, the minister directed the authorities to prioritize procuring emergency medicines and complete all necessary procedures within the stipulated timeframe. Dr Singh also instructed officials to ensure that Brain Health Clinics, on the lines of the one operational at Indira Gandhi Hospital in Dwarka, are established in all districts of Delhi. These clinics will provide comprehensive care and treatment for patients suffering from mental health issues. 'The Brain Health Clinic at Dwarka is receiving an encouraging response from the public. In line with this, we will be setting up similar clinics across all districts to ensure timely mental healthcare for every individual,' said Dr Singh. The Health Minister directed all government hospitals to mandatorily complete the registration process under the Hospital Information Management System (HIMS) as per the standard guidelines. He announced that Model Health Labs will be established to offer all essential diagnostic tests related to general health. At present, 61 private and 25 government hospitals – a total of 86 hospitals – have been empanelled under the Ayushman Bharat scheme in Delhi.
Time of India
4 days ago
- Health
- Time of India
Hassan district reports rise in heart attacks, plans preventive measures
Hassan: There is a concerning increase in heart attack cases among young adults, in Hassan district. A total of 507 cases were reported in the district over the past two years, resulting in 190 deaths. "Depending on the govt funding, plans are being made to conduct screening camps at gram panchayats. The initiative aims to reach more people, particularly in backward areas. Recognising the critical need to educate the public, a widespread awareness programme will be launched with the cooperation of various departments, including education department," said MP Shreyas Patel. He held a meeting with district health officials, private cardiologists, doctors at Hassan Institute of Medical Sciences (HIMS), and representatives from all eight taluks, on Tuesday. The MP emphasised that this is a serious issue requiring immediate attention. In response to questions about whether Covid vaccinations are causing an increase in heart attacks, he clarified that it has been two years since the vaccinations were administered, and currently, there is no specific or official information on this. He advised against creating unnecessary confusion. He mentioned that based on discussions and advice from experts, various measures are suggested to tackle the crisis. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Treatment That Might Help You Against Knee Pain (Search Here) Kneepain | Search Search Now Undo Doctors have been instructed to start special training programme for medical technicians to enhance detecting heart attack at an early stage. He also urged people to adopt a healthy lifestyle, prioritise mental health and engage in yoga, meditation, eat nutritious food, seek expert medical advice, and maintain heart health. The MP instructed that ECG tests be conducted promptly for individuals presenting symptoms of heart attack in rural areas. He directed the purchase of necessary equipment for tests at taluk health centres, stating that the AVRK fund would be utilised for this purchase. HIMS director Dr Rajanna and Dr Sunil were present.
Yahoo
11-06-2025
- Business
- Yahoo
Hims & Hers Health, Inc. (HIMS) Stock Slides as Market Rises: Facts to Know Before You Trade
Hims & Hers Health, Inc. (HIMS) closed at $55.25 in the latest trading session, marking a -2.83% move from the prior day. This change lagged the S&P 500's 0.55% gain on the day. At the same time, the Dow added 0.25%, and the tech-heavy Nasdaq gained 0.63%. Coming into today, shares of the company had gained 2.99% in the past month. In that same time, the Medical sector gained 3.49%, while the S&P 500 gained 6.29%. Market participants will be closely following the financial results of Hims & Hers Health, Inc. in its upcoming release. The company's upcoming EPS is projected at $0.17, signifying a 183.33% increase compared to the same quarter of the previous year. Our most recent consensus estimate is calling for quarterly revenue of $551.84 million, up 74.83% from the year-ago period. For the entire fiscal year, the Zacks Consensus Estimates are projecting earnings of $0.73 per share and a revenue of $2.34 billion, representing changes of +170.37% and +58.31%, respectively, from the prior year. Investors should also take note of any recent adjustments to analyst estimates for Hims & Hers Health, Inc. These revisions help to show the ever-changing nature of near-term business trends. As a result, upbeat changes in estimates indicate analysts' favorable outlook on the company's business health and profitability. Our research suggests that these changes in estimates have a direct relationship with upcoming stock price performance. To utilize this, we have created the Zacks Rank, a proprietary model that integrates these estimate changes and provides a functional rating system. The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate has shifted 5.66% upward. Hims & Hers Health, Inc. is currently a Zacks Rank #2 (Buy). From a valuation perspective, Hims & Hers Health, Inc. is currently exchanging hands at a Forward P/E ratio of 77.39. This valuation marks a premium compared to its industry's average Forward P/E of 27.09. Meanwhile, HIMS's PEG ratio is currently 2.12. Comparable to the widely accepted P/E ratio, the PEG ratio also accounts for the company's projected earnings growth. The Medical Info Systems industry had an average PEG ratio of 2.12 as trading concluded yesterday. The Medical Info Systems industry is part of the Medical sector. This industry currently has a Zacks Industry Rank of 70, which puts it in the top 29% of all 250+ industries. The Zacks Industry Rank assesses the strength of our separate industry groups by calculating the average Zacks Rank of the individual stocks contained within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1. Keep in mind to rely on to watch all these stock-impacting metrics, and more, in the succeeding trading sessions. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Hims & Hers Health, Inc. (HIMS) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
04-06-2025
- Business
- Yahoo
HIMS Stock Falls Despite Latest Deal to Expand International Footprint
Hims & Hers Health, Inc. HIMS announced its agreement to acquire ZAVA, a digital health platform in Europe. The deal, which marks a significant step toward its global expansion, will likely expand HIMS' footprint in the U.K. and will officially launch the company into Germany, France and Ireland, with more markets anticipated soon. The acquisition is expected to close in the second half of 2025, and the deal is expected to be accretive by 2026. Hims & Hers is also planning to introduce a new, personalized dimension of digital health in Europe. Through this, the company aims to provide individuals with access to care tailored to their specific needs and goals across dermatology, weight loss, sexual health and mental health. To ensure a localized experience, this expansion is also expected to include access to British, German and French healthcare providers in local languages. Hims & Hers expects to share more about the offerings and their rollout in the coming months. The latest acquisition and subsequent expansion in the European markets are expected to significantly solidify HIMS' international footprint. Following the announcement, shares of the company lost nearly 3.6% till yesterday's closing. Historically, the company has gained synergies from its various strategic buyouts. Although the latest deal is likely to be beneficial for HIMS' top-line growth going forward, the stock declined overall. Hims & Hers currently has a market capitalization of $12.25 billion. It has an earnings yield of 1.3%, favorable than the industry's negative yield. In the last reported quarter, HIMS delivered an earnings surprise of 66.7%. Hims & Hers aims to establish its own branded presence, leveraging the ZAVA platform in each of the European markets in the coming quarters and strengthening its digital health offerings on a global scale. It is worth mentioning that ZAVA, which currently serves more than 1.3 million active customers, has an in-house medical team that delivered nearly 2.3 million consultations in 2024 across the U.K., Germany, France and Ireland. Hims & Hers' management expects to leverage ZAVA's established European presence to transform access to care for people across Europe battling widespread, often silent chronic conditions like obesity and depression. Per a report by Grand View Research, the global digital health market was estimated at $288.55 billion in 2024 and is anticipated to witness a CAGR of 22.2% between 2025 and 2030. Factors like the rising incidence of chronic conditions fueling the demand for remote monitoring and management solutions, and technological advancements are likely to drive the market. Given the market potential, the latest buyout is expected to be a significant milestone for Hims & Hers and boost its business globally. In February, Hims & Hers acquired a U.S.-based peptide facility based in California. The buyout will likely enable the company to strengthen the long-term durability of its domestic supply chain to meet the growing demand from Americans for personalized healthcare and treatment options. The same month, Hims & Hers acquired an at-home lab testing facility, Sigmund NJ LLC, which is marketed as Trybe Labs. The buyout will likely enable HIMS to support at-home blood draws and more comprehensive whole-body testing. The acquisition is also expected to broaden the company's ability to offer a wide range of personalized treatments, supplements and medications and accelerate the expansion into new clinical categories, including low testosterone, perimenopausal and menopausal support. Shares of the company have surged 154.1% in the past year compared with the industry's 33.8% rise and the S&P 500's gain of 11.4%. Image Source: Zacks Investment Research Currently, HIMS carries a Zacks Rank #2 (Buy). A few other top-ranked stocks in the broader medical space are HealthEquity, Inc. HQY, Cencora, Inc. COR and Integer Holdings Corporation ITGR. HealthEquity, carrying a Zacks Rank #2 at present, has an estimated long-term growth rate of 20.3%. HQY's earnings surpassed estimates in three of the trailing four quarters and missed once, the average surprise being 12.4%. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. HealthEquity's shares have gained 34.9% against the industry's 21.7% decline in the past year. Cencora, carrying a Zacks Rank of 2 at present, has an estimated long-term growth rate of 12.8%. COR's earnings surpassed estimates in each of the trailing four quarters, the average surprise being 6%. Cencora has rallied 25.3% against the industry's 21.7% decline in the past year. Integer Holdings, sporting a Zacks Rank of 1 at present, has an estimated long-term growth rate of 18.4%. ITGR's earnings surpassed estimates in three of the trailing four quarters and missed once, the average surprise being 2.8%. Integer Holdings' shares have lost 0.7% compared with the industry's 13.2% plunge in the past year. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Cencora, Inc. (COR) : Free Stock Analysis Report HealthEquity, Inc. (HQY) : Free Stock Analysis Report Integer Holdings Corporation (ITGR) : Free Stock Analysis Report Hims & Hers Health, Inc. (HIMS) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
